Nelson Pamela E. 4
4 · Lyra Therapeutics, Inc. · Filed Aug 5, 2020
Insider Transaction Report
Form 4
Nelson Pamela E.
Senior VP, Regulatory Affairs
Transactions
- Award
Stock Option
2020-08-03+35,000→ 35,000 totalExercise: $13.68Exp: 2030-08-03→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to 25% of the shares on August 3, 2021 and in 36 equal monthly installments thereafter.